Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study

Data on the use of azacytidine and decitabine as salvage therapy for acute myeloid leukemia are limited. We retrospectively reviewed clinical records of 100 patients treated with hypomethylating agents (HMA) as salvage therapy in nine Italian institutions. A total of 24% of patients obtained a respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lessi, Federica, Laurino, Marica, Papayannidis, Cristina, Vitagliano, Orsola, Grimaldi, Francesco, Lazzarotto, Davide, Gottardi, Michele, Crisà, Elena, Riva, Marta, Reda, Gianluigi, Ermani, Mario, Semenzato, Gianpietro, Trentin, Livio, Ferrara, Felicetto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394759/
https://www.ncbi.nlm.nih.gov/pubmed/34440176
http://dx.doi.org/10.3390/biomedicines9080972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394759/
https://www.ncbi.nlm.nih.gov/pubmed/34440176
http://dx.doi.org/10.3390/biomedicines9080972

Ejemplares similares